PV Bulletin

Partial Revision of the Regulations on the Management of Safety Information for Medical Devices

The MFDS has revised the regulations overseeing the management of safety information related to medical devices, affecting reporting standards and workflows.

Primary source: Ministry of Food and Drug Safety (MFDS)

PV Impact Brief

Urgency: HighConfidence: high

What changed

The reporting and management requirements for adverse events of medical devices have been partially amended, potentially introducing new reporting criteria and electronic formats.

Why it matters

Manufacturers must ensure that their safety reporting systems adherently align with the updated regulations to maintain compliance and enhance post-marketing safety management practices.

Action needed

Manufacturers and stakeholders in South Korea must review and update their safety reporting systems and Standard Operating Procedures (SOPs) to comply with the revised regulations.

Relevant for
Regulatory Intelligence LeadQPPV
Processes impacted
ICSRCountry Compliance
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Policy change details

Document type
Consultation / Administrative Notice
Policy status
Consultation
Publication date
2026-08-13
Policy change
The MFDS issued an administrative notice for the partial amendment of the 'Regulations on the Management of Safety Information such as Adverse Events of Medical Devices.' This revision aims to modernize and clarify the reporting and management requirements for medical device adverse events and safety information.

Key changes

Modernization of adverse event reporting criteria for medical devices; clarification of safety information management procedures; potential introduction of new electronic reporting formats or timelines for vigilance data submission.

Affected workflows

ICSRCountry Compliance

Responsible groups

Medical Device VigilancePharmacovigilanceRegulatory Affairs

Document identifiers

제2026-402호

PV impact

The revision may introduce new criteria or updated electronic reporting methods for medical device vigilance. Manufacturers and stakeholders in the South Korean market must review these changes to ensure their safety reporting systems and SOPs are aligned with the updated post-marketing safety management framework.

View regulator source

Source document details

Extracted documents

Evidence and confidence

Confidence: highSource updated: Aug 13, 2026

Full briefing

Practical implication

Manufacturers and stakeholders in South Korea must review and update their safety reporting systems and Standard Operating Procedures (SOPs) to comply with the revised regulations.

The MFDS issued an administrative notice to update the Regulations on the Management of Safety Information such as Adverse Events of Medical Devices. This revision aims to modernize reporting criteria and clarify safety information management processes, potentially introducing new electronic reporting formats and timelines.

What changed: The reporting and management requirements for adverse events of medical devices have been partially amended, potentially introducing new reporting criteria and electronic formats.

Why it matters: Manufacturers must ensure that their safety reporting systems adherently align with the updated regulations to maintain compliance and enhance post-marketing safety management practices.

Practical implication: Manufacturers and stakeholders in South Korea must review and update their safety reporting systems and Standard Operating Procedures (SOPs) to comply with the revised regulations.

View original source

Published from the Firecrawl policy change extraction pipeline.

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Atellica CH Revised C-Reactive Protein (RCRP) Safety Information - Siemens Healthcare Diagnostics

Urgency: High

Laboratories must implement the safety measures as indicated by the action registration number R2625739, effective from the notice date of September 7, 2026.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward